DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Neoral (Cyclosporine) - Interstitial Lung Disease - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Interstitial Lung Disease (35)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neoral (Cyclosporine) where reactions include interstitial lung disease. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 35   Next >>

Possible Neoral side effects in 3 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-08

Patient: 3 year old female

Reactions: Cytomegalovirus Hepatitis, Hepatic Function Abnormal, Bronchiectasis, Interstitial Lung Disease, Anaemia Haemolytic Autoimmune, Combined Immunodeficiency

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Dexamethasone; Prednisolone; Ganciclovir



Possible Neoral side effects in 64 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-30

Patient: 64 year old male

Reactions: Interstitial Lung Disease, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Cyclophosphamide



Possible Neoral side effects in 64 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-27

Patient: 64 year old male

Reactions: Interstitial Lung Disease, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Cyclophosphamide



Possible Neoral side effects in 64 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-27

Patient: 64 year old male

Reactions: Interstitial Lung Disease, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Cyclophosphamide



Possible Neoral side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18

Patient: male

Reactions: Gastrointestinal Haemorrhage, Coagulopathy, Disseminated Intravascular Coagulation, Enterococcal Infection, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Anal Fistula, Pneumocystis Jiroveci Pneumonia, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Restlessness, Gastrointestinal Ulcer Haemorrhage, Anaemia, Hyperglycaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Ileal Fistula, Large Intestinal Ulcer, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Purulence, Anal Haemorrhage, Hypertension

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Rituximab
    Dosage: unk ukn, unk

Prednisolone
    Dosage: 10 mg, daily
    Administration route: Oral
    End date: 2011-03-18

Neoral
    Dosage: 50 mg, daily
    Administration route: Oral
    Indication: Renal Transplant
    End date: 2011-03-15

Bredinin
    Dosage: 100 mg, daily
    Administration route: Oral
    End date: 2011-03-08

Mycophenolate Mofetil
    Indication: Renal Transplant

Prograf
    Dosage: 2 mg, daily
    Administration route: Oral
    End date: 2011-11-17

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral
    Start date: 2010-11-18
    End date: 2011-03-15

Prednisolone
    Dosage: 10 mg, unk
    End date: 2011-03-22

Other drugs received by patient: Insulin



Possible Neoral side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18

Patient: male

Reactions: Gastrointestinal Haemorrhage, Disseminated Intravascular Coagulation, Enterococcal Infection, Coagulopathy, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Pneumocystis Jiroveci Pneumonia, Anal Fistula, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Gastrointestinal Ulcer Haemorrhage, Restlessness, Hyperglycaemia, Anaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Large Intestinal Ulcer, Ileal Fistula, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Anal Haemorrhage, Purulence, Hypertension

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Bredinin
    Dosage: 100 mg, daily
    Administration route: Oral
    End date: 2011-03-08

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral
    Start date: 2010-11-18
    End date: 2011-03-15

Rituximab
    Dosage: unk ukn, unk

Prograf
    Dosage: 2 mg, daily
    Administration route: Oral
    End date: 2011-11-17

Prednisolone
    Dosage: 10 mg, unk
    End date: 2011-03-22

Prednisolone
    Dosage: 10 mg, daily
    Administration route: Oral
    End date: 2011-03-18

Neoral
    Dosage: 50 mg, daily
    Administration route: Oral
    Indication: Renal Transplant
    End date: 2011-03-15

Mycophenolate Mofetil
    Indication: Renal Transplant

Other drugs received by patient: Insulin



Possible Neoral side effects in male

Reported by a physician from China on 2012-07-16

Patient: male, weighing 50.0 kg (110.0 pounds)

Reactions: Weight Decreased, Fatigue, Interstitial Lung Disease, Diabetes Mellitus, DRY Mouth, Lung Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral
    Indication: Prophylaxis Against Transplant Rejection

Mycophenolic Acid
    Dosage: 1500 mg, daily
    Administration route: Oral
    Indication: Prophylaxis Against Transplant Rejection
    Start date: 2012-01-04

Neoral
    Dosage: 200 mg, daily
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2012-01-04
    End date: 2012-06-11



Possible Neoral side effects in 65 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-18

Patient: 65 year old male

Reactions: Portal Hypertension, Hepatic Function Abnormal, Polyarteritis Nodosa, Hepatic Failure, Pulmonary Fibrosis, Ascites, Renal Impairment, Interstitial Lung Disease, Nodular Regenerative Hyperplasia, Chronic Hepatitis, Necrosis of Artery, Hepatic Cirrhosis, Arterial Stenosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Prednisolone; Prednisolone; Oxygen



Possible Neoral side effects in 65 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-18

Patient: 65 year old male

Reactions: Portal Hypertension, Polyarteritis Nodosa, Hepatic Function Abnormal, Hepatic Failure, Pulmonary Fibrosis, Ascites, Renal Impairment, Interstitial Lung Disease, Nodular Regenerative Hyperplasia, Chronic Hepatitis, Hepatic Cirrhosis, Arterial Stenosis, Necrosis of Artery

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Prednisolone; Prednisolone; Oxygen



Possible Neoral side effects in 65 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-18

Patient: 65 year old male

Reactions: Portal Hypertension, Hepatic Function Abnormal, Polyarteritis Nodosa, Hepatic Failure, Ascites, Pulmonary Fibrosis, Renal Impairment, Interstitial Lung Disease, Nodular Regenerative Hyperplasia, Chronic Hepatitis, Necrosis of Artery, Hepatic Cirrhosis, Arterial Stenosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Prednisolone; Prednisolone; Oxygen



Possible Neoral side effects in male

Reported by a physician from Japan on 2012-06-14

Patient: male, weighing 63.0 kg (138.6 pounds)

Reactions: Drug Ineffective, Conjunctivitis, Malnutrition, Hypoglycaemia, Hyperuricaemia, Dysgeusia, Multi-Organ Failure, Renal Failure, Interstitial Lung Disease, Oedema Peripheral, Bronchitis

Adverse event resulted in: death

Drug(s) suspected as cause:
Stelara
    Indication: Psoriasis
    Start date: 2011-08-10
    End date: 2011-09-07

Oxarol
    Administration route: Topical
    Indication: Psoriasis
    Start date: 2011-10-04
    End date: 2011-11-02

Neoral
    Administration route: Oral
    Indication: Psoriasis
    Start date: 2011-10-04
    End date: 2011-10-21

Neoral
    Administration route: Oral
    End date: 2011-09-05

Other drugs received by patient: Cholebrine; Insulin; Metformin HCL; Polaprezinc; Ensure; Lasix; Urinorm; Ferrous Citrate; Juvelan; Amaryl; Nerisona; Levofloxacin; Rheumatrex; Allegra; Dovonex; Insulin Glargine; Loxonin; Vitamedin; Levofloxacin; Lansoprazole; Rebamipide



Possible Neoral side effects in female

Reported by a physician from Japan on 2012-06-07

Patient: female, weighing 13.0 kg (28.6 pounds)

Reactions: Nasopharyngitis, Nausea, Pyrexia, Respiratory Syncytial Virus Infection, Renal Impairment, Diarrhoea, Interstitial Lung Disease, Heart Transplant Rejection, Rash Erythematous, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prograf
    Dosage: 4.5 mg, unk
    Administration route: Oral
    Start date: 2006-01-23
    End date: 2006-02-16

Certican
    Dosage: 1 mg, unk
    Administration route: Oral
    Start date: 2006-01-30
    End date: 2006-02-03

Certican
    Dosage: 0.75 mg, unk
    Administration route: Oral
    Start date: 2006-02-03
    End date: 2006-04-24

Certican
    Dosage: 0.5 mg, unk
    Administration route: Oral
    Indication: Heart Transplant
    Start date: 2006-01-23
    End date: 2006-01-30

Neoral
    Indication: Heart Transplant

Cellcept
    Administration route: Oral
    Indication: Heart Transplant
    Start date: 2009-02-01

Certican
    Dosage: 1 mg, daily
    Administration route: Oral
    Start date: 2008-01-23
    End date: 2009-01-22

Azathioprine
    Administration route: Oral
    Indication: Heart Transplant

Tacrolimus
    Indication: Heart Transplant

Prograf
    Dosage: 4.8 mg, unk
    Administration route: Oral
    Indication: Heart Transplant
    End date: 2006-01-23

Prograf
    Dosage: 4.0 mg, unk
    Administration route: Oral
    Start date: 2006-03-20
    End date: 2006-04-24

Certican
    Dosage: unk
    Administration route: Oral
    End date: 2009-02-05

Certican
    Dosage: unk

Prograf
    Dosage: 3.0 mg, unk
    Administration route: Oral
    Start date: 2006-02-16
    End date: 2006-03-20

Other drugs received by patient: Everolimus; Tenormin; Sirolimus; Famotidine



Possible Neoral side effects in 63 year old male

Reported by a physician from Japan on 2012-05-23

Patient: 63 year old male

Reactions: Dysgeusia, Drug Level Increased, Interstitial Lung Disease, Drug Interaction, Pyrexia, Cough

Drug(s) suspected as cause:
Neoral

Other drugs received by patient possibly interacting with the suspect drug:
Afinitor
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2012-04-14
    End date: 2012-04-16

Afinitor
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Renal Cell Carcinoma
    Start date: 2012-03-27
    End date: 2012-04-13



Possible Neoral side effects in 68 year old male

Reported by a pharmacist from Japan on 2012-05-22

Patient: 68 year old male

Reactions: Interstitial Lung Disease

Drug(s) suspected as cause:
Neoral



Possible Neoral side effects in 63 year old male

Reported by a physician from Japan on 2012-05-15

Patient: 63 year old male

Reactions: Interstitial Lung Disease, Drug Level Increased, Drug Interaction, Pyrexia, Cough

Drug(s) suspected as cause:
Neoral

Other drugs received by patient possibly interacting with the suspect drug:
Afinitor
    Dosage: 5 mg, unk
    Administration route: Oral
    Start date: 2012-04-14
    End date: 2012-04-16

Afinitor
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Renal Cell Carcinoma
    Start date: 2012-03-27
    End date: 2012-04-13



Possible Neoral side effects in male

Reported by a physician from Japan on 2012-05-04

Patient: male, weighing 63.0 kg (138.6 pounds)

Reactions: Diabetes Mellitus, Drug Ineffective, Malnutrition, Conjunctivitis, Hyperuricaemia, Blood Glucose Decreased, Multi-Organ Failure, Dysgeusia, Renal Failure, Interstitial Lung Disease, Oedema Peripheral, Bronchitis

Adverse event resulted in: death

Drug(s) suspected as cause:
Stelara
    Indication: Psoriasis
    Start date: 2011-08-10
    End date: 2011-09-07

Neoral
    Administration route: Oral
    Indication: Psoriasis
    Start date: 2011-10-04
    End date: 2011-10-21

Oxarol
    Administration route: Topical
    Indication: Psoriasis
    Start date: 2011-10-04
    End date: 2011-11-02

Neoral
    Administration route: Oral
    End date: 2011-09-05

Other drugs received by patient: Levofloxacin; Ensure; Insulin; Dovonex; Insulin Glargine; Allegra; Nerisona; Ferrous Citrate; Juvelan; Urinorm; Cholebrine; Amaryl; Rheumatrex; Polaprezinc; Rebamipide; Loxonin; Lasix; Vitamedin; Lansoprazole; Metformin HCL; Levofloxacin



Possible Neoral side effects in 68 year old male

Reported by a pharmacist from Japan on 2012-05-02

Patient: 68 year old male

Reactions: Interstitial Lung Disease

Drug(s) suspected as cause:
Neoral



Possible Neoral side effects in 63 year old male

Reported by a physician from Japan on 2012-05-02

Patient: 63 year old male

Reactions: Drug Level Increased, Interstitial Lung Disease, Drug Interaction, Pyrexia, Cough

Drug(s) suspected as cause:
Neoral

Other drugs received by patient possibly interacting with the suspect drug:
Afinitor
    Dosage: 5 mg, unk
    Administration route: Oral
    Start date: 2012-04-14
    End date: 2012-04-16

Afinitor
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Renal Cell Carcinoma
    Start date: 2012-03-27
    End date: 2012-04-13



Possible Neoral side effects in 63 year old male

Reported by a physician from Japan on 2012-04-27

Patient: 63 year old male

Reactions: Interstitial Lung Disease, Drug Level Increased, Drug Interaction, Pyrexia, Cough

Drug(s) suspected as cause:
Neoral

Other drugs received by patient possibly interacting with the suspect drug:
Afinitor
    Dosage: 5 mg, unk
    Administration route: Oral
    Start date: 2012-04-14
    End date: 2012-04-16

Afinitor
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Renal Cell Carcinoma
    Start date: 2012-03-27
    End date: 2012-04-13



Possible Neoral side effects in 25 year old male

Reported by a consumer/non-health professional from Japan on 2012-04-23

Patient: 25 year old male, weighing 57.0 kg (125.4 pounds)

Reactions: Eyelid Oedema, Pneumonia Viral, Gastrointestinal Haemorrhage, Hepatic Function Abnormal, Graft Versus Host Disease, Disseminated Intravascular Coagulation, Headache, Pyrexia, Oral Herpes, Pneumonia Cytomegaloviral, Generalised Oedema, Pericardial Effusion, Pneumocystis Jiroveci Pneumonia, Interstitial Lung Disease, Liver Function Test Abnormal, Pleural Effusion, Enterocolitis, Bronchopulmonary Aspergillosis, White Blood Cell Count Decreased, Anaemia, Pulmonary Haemorrhage, Renal Impairment, Platelet Count Decreased, Neutrophil Count Decreased

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Itraconazole
    Dosage: capsule;400-200mg/day(06jul-16jul09)inj.
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2009-06-06
    End date: 2009-07-16

Foscavir
    Dosage: form:inj1 df= 10 unit nos
    Start date: 2009-07-10
    End date: 2009-07-16

Bactrim
    Dosage: 1df=1tab;800mg/day(02jul-18jul09)inj.
    Administration route: Oral
    Indication: Antibiotic Prophylaxis
    Start date: 2009-04-14
    End date: 2009-07-16

Farom
    Administration route: Oral
    Start date: 2009-04-28
    End date: 2009-05-01

Neoral
    Dosage: 09jul-16jul09. 125mg/day sandimmun:inj:50mg/dy:09jul-16jul09
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2009-04-14
    End date: 2009-07-08

Sprycel
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-04-16
    End date: 2009-07-08

Maxipime
    Start date: 2009-04-24
    End date: 2009-04-27

Other drugs received by patient: Ceftazidime; Solu-Medrol; Ambisome; Piperacillin and Tazobactam; Pentamidine Isethionate; Ganciclovir; Meropenem; Omegacin; Sandimmune; Prednisolone



Possible Neoral side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-20

Patient: male

Reactions: Gastrointestinal Haemorrhage, Enterococcal Infection, Coagulopathy, Disseminated Intravascular Coagulation, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Anal Fistula, Pneumocystis Jiroveci Pneumonia, Colonic Fistula, Circulatory Collapse, Acute Respiratory Distress Syndrome, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Restlessness, Gastrointestinal Ulcer Haemorrhage, Hyperglycaemia, Anaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Shock Haemorrhagic, Oral Administration Complication, Ileal Ulcer, Large Intestinal Ulcer, Ileal Fistula, Interstitial Lung Disease, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Respiratory Failure, Diarrhoea, Sepsis, Purulence, Anal Haemorrhage, Hypertension

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Bredinin
    Dosage: 100 mg, daily
    Administration route: Oral
    End date: 2011-03-08

Prednisolone
    Dosage: 10 mg, unk
    End date: 2011-03-22

Prograf
    Dosage: 2 mg, daily
    Administration route: Oral
    Start date: 2006-11-01
    End date: 2011-11-17

Rituximab
    Dosage: unk ukn, unk

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral
    Start date: 2010-11-18
    End date: 2011-03-15

Prednisolone
    Dosage: 10 mg, daily
    Administration route: Oral
    Start date: 2006-11-01
    End date: 2011-03-18

Neoral
    Dosage: 50 mg, daily
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-11-18
    End date: 2011-03-15

Other drugs received by patient: Insulin



Possible Neoral side effects in 72 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-10

Patient: 72 year old female

Reactions: Dyspnoea, Interstitial Lung Disease, Rash, Pyrexia, Cough

Drug(s) suspected as cause:
Infliximab
    Dosage: unk ukn, unk
    Start date: 2010-08-01

Adalimumab
    Dosage: unk ukn, unk
    Indication: Psoriasis

Neoral
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Psoriasis
    End date: 2010-08-01

Other drugs received by patient: Humira



Possible Neoral side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-10

Patient: 50 year old male

Reactions: Renal Impairment, Interstitial Lung Disease, Cell Marker Increased

Drug(s) suspected as cause:
Sandimmune
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Erythrodermic Psoriasis
    Start date: 1994-01-01

Neoral
    Indication: Erythrodermic Psoriasis

Remicade
    Dosage: unk ukn, unk
    Indication: Erythrodermic Psoriasis
    Start date: 2008-08-01
    End date: 2011-05-01

Neoral
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Psoriasis
    Start date: 1994-01-01
    End date: 2008-08-01



Possible Neoral side effects in 72 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-10

Patient: 72 year old female

Reactions: Dyspnoea, Interstitial Lung Disease, Rash, Pyrexia, Cough

Drug(s) suspected as cause:
Infliximab
    Dosage: unk ukn, unk
    Start date: 2010-08-01

Neoral
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Psoriasis
    End date: 2010-08-01

Adalimumab
    Dosage: unk ukn, unk
    Indication: Psoriasis

Other drugs received by patient: Humira



Possible Neoral side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-10

Patient: 55 year old male

Reactions: Interstitial Lung Disease, Arthralgia, Cell Marker Increased

Drug(s) suspected as cause:
Remicade
    Dosage: unk ukn, unk
    Indication: Psoriatic Arthropathy
    Start date: 2008-08-01
    End date: 2010-03-01

Neoral
    Indication: Psoriasis

Neoral
    Dosage: unk ukn, unk
    Indication: Psoriatic Arthropathy
    Start date: 1990-01-01
    End date: 2008-08-01



Possible Neoral side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-10

Patient: 55 year old male

Reactions: Arthralgia, Interstitial Lung Disease, Cell Marker Increased

Drug(s) suspected as cause:
Remicade
    Dosage: unk ukn, unk
    Indication: Psoriatic Arthropathy
    Start date: 2008-08-01
    End date: 2010-03-01

Neoral
    Dosage: unk ukn, unk
    Indication: Psoriatic Arthropathy
    Start date: 1990-01-01
    End date: 2008-08-01

Neoral
    Indication: Psoriasis



Possible Neoral side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-10

Patient: 50 year old male

Reactions: Renal Impairment, Interstitial Lung Disease, Cell Marker Increased

Drug(s) suspected as cause:
Sandimmune
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Erythrodermic Psoriasis
    Start date: 1994-01-01

Neoral
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Psoriasis
    Start date: 1994-01-01
    End date: 2008-08-01

Neoral
    Indication: Erythrodermic Psoriasis

Remicade
    Dosage: unk ukn, unk
    Indication: Erythrodermic Psoriasis
    Start date: 2008-08-01
    End date: 2011-05-01



Possible Neoral side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-14

Patient: male

Reactions: Gastrointestinal Haemorrhage, Endocarditis Bacterial, Aortic Stenosis, Tricuspid Valve Incompetence, Death, Colonic Polyp, Dyspnoea Exertional, Interstitial Lung Disease, Cerebral Artery Embolism, Blindness Unilateral, Hypoxia, Acute Myocardial Infarction, Cardiac Failure Congestive, Malnutrition, Renal Failure Chronic, Cerebrovascular Accident, Hyperlipidaemia, Renal Impairment, Embolism, Mitral Valve Incompetence, Leukocytosis, Aortic Valve Incompetence, Hypertension, Mitral Valve Stenosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 75 mg, unk

Neoral
    Dosage: 25 mg, bid
    Administration route: Oral

Neoral
    Dosage: 125 mg, unk
    Administration route: Oral

Other drugs received by patient: Citalopram; Temazepam; Metoprolol; Renagel; Azathioprine; Penicillin; Cipro; Ultram; Prednisone; Albuterol; Sodium Bicarbonate; Buspar; Acetaminophen; Guaifenesin; Ativan; Ambien; Celexa; Vitamin D; Simvastatin; Lovastatin



Possible Neoral side effects in

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-02-22

Patient:

Reactions: Interstitial Lung Disease

Drug(s) suspected as cause:
Certican
    Dosage: 0.25 mg, bid
    Indication: Heart Transplant

Neoral
    Dosage: unk ukn, unk
    Indication: Renal Transplant



Possible Neoral side effects in female

Reported by a physician from Belgium on 2011-12-15

Patient: female, weighing 56.2 kg (123.6 pounds)

Reactions: Diabetes Mellitus, Interstitial Lung Disease, Anaemia, Blood Creatinine Increased, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 50 mg, bid
    Indication: Renal Transplant

Everolimus
    Dosage: 3 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2009-12-05
    End date: 2011-09-23

Prednisolone
    Dosage: 4 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2009-11-07

Myfortic
    Dosage: 720 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2009-12-16

Other drugs received by patient: Glurenorm; Olmesartan Medoxomil; Bumetanide; Insulatard NPH Human; Sulfamethoxazole and Trimethoprim



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012